世界胃肠病学杂志:英文版(电子版), ISSN 1007-9327, 2014, Volume 20, Issue 47, pp. 17819 - 17829
Enterolithiasis or formation of gastrointestinal concretions is an uncommon medical condition that develops in the setting of intestinal stasis in the presence...
Enterolithiasis | ileus | obstruc | Gallstone | Intestinal | Gallstone ileus | Intestinal tuberculosis | Diverticulosis | Intestinal obstruction | Crohn's disease | Meckel's diverticulum | CROHNS-DISEASE | SMALL-BOWEL OBSTRUCTION | MECKELS-DIVERTICULUM | DUODENAL DIVERTICULUM | AFFERENT LOOP SYNDROME | JEJUNAL DIVERTICULOSIS | ELECTROHYDRAULIC LITHOTRIPSY | GASTROENTEROLOGY & HEPATOLOGY | INTESTINAL-OBSTRUCTION | PERFORATION | History, 17th Century | Predictive Value of Tests | Gastrointestinal Diseases - mortality | Gastrointestinal Diseases - physiopathology | History, 20th Century | Humans | Risk Factors | Lithiasis - therapy | Lithiasis - history | Gastrointestinal Diseases - therapy | Treatment Outcome | Gastrointestinal Diseases - diagnosis | Gastrointestinal Diseases - history | Lithiasis - physiopathology | Animals | Lithiasis - diagnosis | Lithiasis - mortality | Meckel’s diverticulum | Minireviews | Crohn’s disease
Enterolithiasis | ileus | obstruc | Gallstone | Intestinal | Gallstone ileus | Intestinal tuberculosis | Diverticulosis | Intestinal obstruction | Crohn's disease | Meckel's diverticulum | CROHNS-DISEASE | SMALL-BOWEL OBSTRUCTION | MECKELS-DIVERTICULUM | DUODENAL DIVERTICULUM | AFFERENT LOOP SYNDROME | JEJUNAL DIVERTICULOSIS | ELECTROHYDRAULIC LITHOTRIPSY | GASTROENTEROLOGY & HEPATOLOGY | INTESTINAL-OBSTRUCTION | PERFORATION | History, 17th Century | Predictive Value of Tests | Gastrointestinal Diseases - mortality | Gastrointestinal Diseases - physiopathology | History, 20th Century | Humans | Risk Factors | Lithiasis - therapy | Lithiasis - history | Gastrointestinal Diseases - therapy | Treatment Outcome | Gastrointestinal Diseases - diagnosis | Gastrointestinal Diseases - history | Lithiasis - physiopathology | Animals | Lithiasis - diagnosis | Lithiasis - mortality | Meckel’s diverticulum | Minireviews | Crohn’s disease
Journal Article
Journal of Pediatric Surgery, ISSN 0022-3468, 2017, Volume 52, Issue 9, pp. 1398 - 1408
Abstract Background The indications of esophageal replacement (ER) in pediatric patients include long gap esophageal atresia (LGEA), intractable post-corrosive...
Pediatrics | Surgery | Reflux | Long-term follow up | Dysphagia | Children | Esophageal replacement | Quality of life | SURGERY | RECONSTRUCTION | COLOGASTRIC ANASTOMOSIS | FOLLOW-UP | ESOPHAGECTOMY | GASTRIC PULL-UP | ATRESIA | PEDIATRICS | COLON INTERPOSITION | JEJUNAL INTERPOSITION | Esophageal Stenosis - physiopathology | Child Welfare | Esophagoplasty - statistics & numerical data | Jejunum - surgery | Esophageal Atresia - physiopathology | Esophageal Stenosis - surgery | Esophageal Diseases - physiopathology | Humans | Esophageal Diseases - surgery | Infant | Child | Esophageal Atresia - surgery | Health aspects | Analysis
Pediatrics | Surgery | Reflux | Long-term follow up | Dysphagia | Children | Esophageal replacement | Quality of life | SURGERY | RECONSTRUCTION | COLOGASTRIC ANASTOMOSIS | FOLLOW-UP | ESOPHAGECTOMY | GASTRIC PULL-UP | ATRESIA | PEDIATRICS | COLON INTERPOSITION | JEJUNAL INTERPOSITION | Esophageal Stenosis - physiopathology | Child Welfare | Esophagoplasty - statistics & numerical data | Jejunum - surgery | Esophageal Atresia - physiopathology | Esophageal Stenosis - surgery | Esophageal Diseases - physiopathology | Humans | Esophageal Diseases - surgery | Infant | Child | Esophageal Atresia - surgery | Health aspects | Analysis
Journal Article
Pharmacological Research, ISSN 1043-6618, 09/2016, Volume 111, pp. 838 - 848
The pacemaker function of interstitial cells of Cajal (ICC) is impaired during intestinal inflammation. The aim of this study is to clarify the...
Intestinal inflammation | Oxidative stress | Gastrointestinal motility | Interstitial cells of Cajal | Nitric oxide | ELECTRICAL RHYTHMICITY | MOTILITY DISORDER | INTESTINE | S-NITROSYLATION | MUSCULARIS RESIDENT MACROPHAGES | LIPOPOLYSACCHARIDE | PHARMACOLOGY & PHARMACY | SPONTANEOUS RHYTHMICITY | TNF-ALPHA | UP-REGULATION | EXPRESSION | Muscle, Smooth - ultrastructure | Proto-Oncogene Proteins c-kit - metabolism | Biological Clocks - drug effects | Jejunum - metabolism | Jejunum - drug effects | Jejunum - ultrastructure | Interstitial Cells of Cajal - metabolism | Muscle, Smooth - drug effects | Jejunum - physiopathology | Time Factors | Nitric Oxide Synthase Type II - antagonists & inhibitors | Jejunal Diseases - physiopathology | Proto-Oncogene Proteins c-kit - genetics | Nitric Oxide Donors - pharmacology | Cytokines - genetics | Enteritis - metabolism | Jejunal Diseases - metabolism | Calcium Signaling | Cytokines - metabolism | Nitric Oxide Donors - metabolism | Cells, Cultured | Enzyme Inhibitors - pharmacology | Interstitial Cells of Cajal - drug effects | Mice, Transgenic | Enteritis - pathology | Muscle, Smooth - metabolism | Enteritis - physiopathology | Animals | Muscle, Smooth - physiopathology | Interstitial Cells of Cajal - ultrastructure | Jejunal Diseases - pathology | Mice, Inbred BALB C | Oxidative Stress - drug effects | Nitric Oxide - metabolism | Nitric Oxide Synthase Type II - metabolism | Physiological aspects | Medical colleges | Neurosciences | Cells | Platelet-derived growth factor | Interleukins | Cell death | Inflammation | Interferon | Biological response modifiers | Mitogens
Intestinal inflammation | Oxidative stress | Gastrointestinal motility | Interstitial cells of Cajal | Nitric oxide | ELECTRICAL RHYTHMICITY | MOTILITY DISORDER | INTESTINE | S-NITROSYLATION | MUSCULARIS RESIDENT MACROPHAGES | LIPOPOLYSACCHARIDE | PHARMACOLOGY & PHARMACY | SPONTANEOUS RHYTHMICITY | TNF-ALPHA | UP-REGULATION | EXPRESSION | Muscle, Smooth - ultrastructure | Proto-Oncogene Proteins c-kit - metabolism | Biological Clocks - drug effects | Jejunum - metabolism | Jejunum - drug effects | Jejunum - ultrastructure | Interstitial Cells of Cajal - metabolism | Muscle, Smooth - drug effects | Jejunum - physiopathology | Time Factors | Nitric Oxide Synthase Type II - antagonists & inhibitors | Jejunal Diseases - physiopathology | Proto-Oncogene Proteins c-kit - genetics | Nitric Oxide Donors - pharmacology | Cytokines - genetics | Enteritis - metabolism | Jejunal Diseases - metabolism | Calcium Signaling | Cytokines - metabolism | Nitric Oxide Donors - metabolism | Cells, Cultured | Enzyme Inhibitors - pharmacology | Interstitial Cells of Cajal - drug effects | Mice, Transgenic | Enteritis - pathology | Muscle, Smooth - metabolism | Enteritis - physiopathology | Animals | Muscle, Smooth - physiopathology | Interstitial Cells of Cajal - ultrastructure | Jejunal Diseases - pathology | Mice, Inbred BALB C | Oxidative Stress - drug effects | Nitric Oxide - metabolism | Nitric Oxide Synthase Type II - metabolism | Physiological aspects | Medical colleges | Neurosciences | Cells | Platelet-derived growth factor | Interleukins | Cell death | Inflammation | Interferon | Biological response modifiers | Mitogens
Journal Article
Gut, ISSN 0017-5749, 08/2009, Volume 58, Issue 8, pp. 1084 - 1090
Background and Aims:Small bowel manometry is increasingly used in the clinical investigation of patients with symptoms of intestinal motor dysfunction. Enteric...
DIAGNOSIS | NEUROMUSCULAR DISORDERS | VISCERAL NEUROPATHY | JEJUNAL MOTILITY | MANOMETRY | MUSCLE ALPHA-ACTIN | SYSTEMIC-SCLEROSIS | GASTROENTEROLOGY & HEPATOLOGY | GASTROINTESTINAL MOTOR DYSFUNCTION | IRRITABLE-BOWEL-SYNDROME | PSEUDO-OBSTRUCTION | Manometry | Myenteric Plexus - pathology | Gastrointestinal Diseases - physiopathology | Intestine, Small - pathology | Humans | Middle Aged | Gastrointestinal Diseases - etiology | Male | Intestinal Pseudo-Obstruction - pathology | Neuritis - pathology | Intestinal Pseudo-Obstruction - physiopathology | Young Adult | Gastrointestinal Motility | Neuritis - complications | Biopsy | Gastrointestinal Diseases - pathology | Intestine, Small - innervation | Adult | Female | Aged | Chronic Disease | Measurement | Intestines | Obstructions | Motility | Gastrointestinal system | Diagnosis | Research | Studies | Ostomy | Hospitals | Disease | Lymphocytes | Irritable bowel syndrome | Family medical history | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Gastroenterology and Hepatology | Gastroenterologi
DIAGNOSIS | NEUROMUSCULAR DISORDERS | VISCERAL NEUROPATHY | JEJUNAL MOTILITY | MANOMETRY | MUSCLE ALPHA-ACTIN | SYSTEMIC-SCLEROSIS | GASTROENTEROLOGY & HEPATOLOGY | GASTROINTESTINAL MOTOR DYSFUNCTION | IRRITABLE-BOWEL-SYNDROME | PSEUDO-OBSTRUCTION | Manometry | Myenteric Plexus - pathology | Gastrointestinal Diseases - physiopathology | Intestine, Small - pathology | Humans | Middle Aged | Gastrointestinal Diseases - etiology | Male | Intestinal Pseudo-Obstruction - pathology | Neuritis - pathology | Intestinal Pseudo-Obstruction - physiopathology | Young Adult | Gastrointestinal Motility | Neuritis - complications | Biopsy | Gastrointestinal Diseases - pathology | Intestine, Small - innervation | Adult | Female | Aged | Chronic Disease | Measurement | Intestines | Obstructions | Motility | Gastrointestinal system | Diagnosis | Research | Studies | Ostomy | Hospitals | Disease | Lymphocytes | Irritable bowel syndrome | Family medical history | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Gastroenterology and Hepatology | Gastroenterologi
Journal Article
Pediatrics, ISSN 0031-4005, 07/2006, Volume 118, Issue 1, pp. 124 - 129
BACKGROUND. Growth failure is a recognized complication of pediatric-onset Crohn's disease, but there are few data on final adult height. OBJECTIVE. Our...
Crohn's disease | Height | Adult outcomes | DIAGNOSIS | INFLAMMATORY-BOWEL-DISEASE | GROWTH-RETARDATION | PROGNOSIS | ADOLESCENTS | PEDIATRICS | adult outcomes | FAILURE | height | CHILDREN | Crohn Disease - epidemiology | Multivariate Analysis | Follow-Up Studies | Humans | Child, Preschool | Growth Disorders - etiology | Male | Crohn Disease - complications | Crohn Disease - therapy | Adolescent | Age of Onset | Jejunal Diseases - physiopathology | Adult | Body Height | Female | Crohn Disease - physiopathology | Retrospective Studies | Child | Dwarfism | Causes of | Risk factors | Pediatrics | Adults | Human growth | Patients | Crohns disease
Crohn's disease | Height | Adult outcomes | DIAGNOSIS | INFLAMMATORY-BOWEL-DISEASE | GROWTH-RETARDATION | PROGNOSIS | ADOLESCENTS | PEDIATRICS | adult outcomes | FAILURE | height | CHILDREN | Crohn Disease - epidemiology | Multivariate Analysis | Follow-Up Studies | Humans | Child, Preschool | Growth Disorders - etiology | Male | Crohn Disease - complications | Crohn Disease - therapy | Adolescent | Age of Onset | Jejunal Diseases - physiopathology | Adult | Body Height | Female | Crohn Disease - physiopathology | Retrospective Studies | Child | Dwarfism | Causes of | Risk factors | Pediatrics | Adults | Human growth | Patients | Crohns disease
Journal Article
Pharmacology and Therapeutics, ISSN 0163-7258, 11/2007, Volume 116, Issue 2, pp. 207 - 235
Mast cells are well known as versatile cells capable of releasing and producing a variety of inflammatory mediators upon activation and are often found in...
Inflammatory bowel disease | Mast cell-nerve interaction | Animal models | Mast cells | Enteric nerves | Irritable bowel syndrome | DEXTRAN SULFATE SODIUM | PROTEINASE-ACTIVATED RECEPTOR-2 | animal models | mast cell-nerve interaction | GENE-RELATED PEPTIDE | VASOACTIVE-INTESTINAL-PEPTIDE | irritable bowel syndrome | ENTERIC NERVOUS-SYSTEM | ACID-INDUCED COLITIS | mast cells | inflammatory bowel disease | DELAYED-TYPE HYPERSENSITIVITY | TUMOR-NECROSIS-FACTOR | enteric nerves | PHARMACOLOGY & PHARMACY | RAT JEJUNAL MUCOSA | TNBS-INDUCED COLITIS | Mast Cells - immunology | Neurons - pathology | Enteric Nervous System - pathology | Enteric Nervous System - metabolism | Humans | Inflammatory Bowel Diseases - immunology | Inflammatory Bowel Diseases - physiopathology | Irritable Bowel Syndrome - physiopathology | Animals | Inflammation Mediators - metabolism | Irritable Bowel Syndrome - immunology | Mast Cells - metabolism | Neurons - metabolism | Disease Models, Animal
Inflammatory bowel disease | Mast cell-nerve interaction | Animal models | Mast cells | Enteric nerves | Irritable bowel syndrome | DEXTRAN SULFATE SODIUM | PROTEINASE-ACTIVATED RECEPTOR-2 | animal models | mast cell-nerve interaction | GENE-RELATED PEPTIDE | VASOACTIVE-INTESTINAL-PEPTIDE | irritable bowel syndrome | ENTERIC NERVOUS-SYSTEM | ACID-INDUCED COLITIS | mast cells | inflammatory bowel disease | DELAYED-TYPE HYPERSENSITIVITY | TUMOR-NECROSIS-FACTOR | enteric nerves | PHARMACOLOGY & PHARMACY | RAT JEJUNAL MUCOSA | TNBS-INDUCED COLITIS | Mast Cells - immunology | Neurons - pathology | Enteric Nervous System - pathology | Enteric Nervous System - metabolism | Humans | Inflammatory Bowel Diseases - immunology | Inflammatory Bowel Diseases - physiopathology | Irritable Bowel Syndrome - physiopathology | Animals | Inflammation Mediators - metabolism | Irritable Bowel Syndrome - immunology | Mast Cells - metabolism | Neurons - metabolism | Disease Models, Animal
Journal Article
Internal Medicine, ISSN 0918-2918, 2018, Volume 57, Issue 14, pp. 1995 - 1999
A 69-year-old man was admitted to a hospital with complaints of abdominal pain. Computed tomography showed hepatic portal venous gas and pneumatosis cystoides...
ischemic enteritis | hepatic portal venous gas | pneumatosis cystoides intestinalis | balloon-assisted enteroscopy | intestinal stricture | Balloon-assisted enteroscopy | Intestinal stricture | Ischemic enteritis | Hepatic portal venous gas | Pneumatosis cystoides intestinalis | DIAGNOSIS | MEDICINE, GENERAL & INTERNAL | NECROSIS | SMALL-BOWEL OBSTRUCTION | RISK | CAPSULE ENDOSCOPY | FEATURES | Jejunal Diseases - diagnostic imaging | Enteritis - surgery | Pneumatosis Cystoides Intestinalis - surgery | Humans | Mesenteric Ischemia - diagnostic imaging | Male | Tomography, X-Ray Computed | Treatment Outcome | Pneumatosis Cystoides Intestinalis - physiopathology | Mesenteric Ischemia - physiopathology | Enteritis - physiopathology | Enteritis - diagnostic imaging | Jejunal Diseases - physiopathology | Mesenteric Ischemia - surgery | Aged | Jejunum - diagnostic imaging | Pneumatosis Cystoides Intestinalis - diagnostic imaging | Jejunum | Pain | Computed tomography | Ischemia | Intestine | Vomiting | Liver | Stenosis | Enteritis | Fluoroscopy | Case Report
ischemic enteritis | hepatic portal venous gas | pneumatosis cystoides intestinalis | balloon-assisted enteroscopy | intestinal stricture | Balloon-assisted enteroscopy | Intestinal stricture | Ischemic enteritis | Hepatic portal venous gas | Pneumatosis cystoides intestinalis | DIAGNOSIS | MEDICINE, GENERAL & INTERNAL | NECROSIS | SMALL-BOWEL OBSTRUCTION | RISK | CAPSULE ENDOSCOPY | FEATURES | Jejunal Diseases - diagnostic imaging | Enteritis - surgery | Pneumatosis Cystoides Intestinalis - surgery | Humans | Mesenteric Ischemia - diagnostic imaging | Male | Tomography, X-Ray Computed | Treatment Outcome | Pneumatosis Cystoides Intestinalis - physiopathology | Mesenteric Ischemia - physiopathology | Enteritis - physiopathology | Enteritis - diagnostic imaging | Jejunal Diseases - physiopathology | Mesenteric Ischemia - surgery | Aged | Jejunum - diagnostic imaging | Pneumatosis Cystoides Intestinalis - diagnostic imaging | Jejunum | Pain | Computed tomography | Ischemia | Intestine | Vomiting | Liver | Stenosis | Enteritis | Fluoroscopy | Case Report
Journal Article
Expert Review of Gastroenterology & Hepatology, ISSN 1747-4124, 03/2014, Volume 8, Issue 3, pp. 301 - 312
Recent developments in the field of diabetes and obesity management have established the central role of the gut in glucose homeostasis; not only is the gut...
GLUT2 | bariatric surgery | GLP-1 | SGLT1 | short gut syndrome | critical illness induced hyperglyaemia | gastric emptying | sweet-taste receptor | short gut syndroM.E | HEALTHY-SUBJECTS | SUGAR ABSORPTION | DIABETIC-PATIENTS | GLUCAGON-LIKE PEPTIDE-1 | SHORT-BOWEL SYNDROME | INCRETIN HORMONE-RELEASE | LATE DUMPING SYNDROME | ORAL GLUCOSE | GASTROENTEROLOGY & HEPATOLOGY | CRITICALLY-ILL PATIENTS | SWEET TASTE RECEPTORS | Duodenal Diseases - metabolism | Duodenal Diseases - physiopathology | Humans | Gastrointestinal Motility - physiology | Obesity - physiopathology | Diabetes Mellitus, Type 2 - metabolism | Intestine, Small - physiopathology | Obesity - metabolism | Diabetes Mellitus, Type 2 - physiopathology | Ileal Diseases - physiopathology | Homeostasis - physiology | Jejunal Diseases - physiopathology | Glucose - metabolism | Ileal Diseases - metabolism | Intestine, Small - metabolism | Jejunal Diseases - metabolism | Intestinal Absorption - physiology
GLUT2 | bariatric surgery | GLP-1 | SGLT1 | short gut syndrome | critical illness induced hyperglyaemia | gastric emptying | sweet-taste receptor | short gut syndroM.E | HEALTHY-SUBJECTS | SUGAR ABSORPTION | DIABETIC-PATIENTS | GLUCAGON-LIKE PEPTIDE-1 | SHORT-BOWEL SYNDROME | INCRETIN HORMONE-RELEASE | LATE DUMPING SYNDROME | ORAL GLUCOSE | GASTROENTEROLOGY & HEPATOLOGY | CRITICALLY-ILL PATIENTS | SWEET TASTE RECEPTORS | Duodenal Diseases - metabolism | Duodenal Diseases - physiopathology | Humans | Gastrointestinal Motility - physiology | Obesity - physiopathology | Diabetes Mellitus, Type 2 - metabolism | Intestine, Small - physiopathology | Obesity - metabolism | Diabetes Mellitus, Type 2 - physiopathology | Ileal Diseases - physiopathology | Homeostasis - physiology | Jejunal Diseases - physiopathology | Glucose - metabolism | Ileal Diseases - metabolism | Intestine, Small - metabolism | Jejunal Diseases - metabolism | Intestinal Absorption - physiology
Journal Article
Brazilian Journal of Medical and Biological Research, ISSN 0100-879X, 2017, Volume 50, Issue 5, p. e5858
Modifications in life-style and/or pharmacotherapies contribute to weight loss and ameliorate the metabolic profile of dietinduced obese humans and rodents....
Hepatic fatty acid metabolism | Duodenal-jejunal bypass | Hypothalamic obesity | Ki67 | Insulin secretion | MEDICINE, RESEARCH & EXPERIMENTAL | NERVOUS-SYSTEM | FATTY LIVER-DISEASE | Y GASTRIC BYPASS | INSULIN-SECRETION | BETA-CELL FUNCTION | METABOLISM | GLUCOSE | BIOLOGY | DYNAMICS | BARIATRIC SURGERY | WEIGHT | Liver - pathology | Cell Proliferation | Hypothalamic Diseases - physiopathology | Rats, Wistar | Cholesterol - blood | Hypothalamic Diseases - surgery | Male | Lipogenesis - genetics | Time Factors | Islets of Langerhans - metabolism | Islets of Langerhans - cytology | Islets of Langerhans - physiopathology | Gastric Bypass - methods | Fatty Acids - blood | Insulin Secretion | Animals, Newborn | Obesity - surgery | Reproducibility of Results | Fatty Liver - metabolism | Jejunum - surgery | Fatty Liver - physiopathology | Liver - metabolism | Insulin Resistance | Pancreas - pathology | Hypothalamic Diseases - metabolism | Obesity - physiopathology | Pancreas - metabolism | Random Allocation | Fatty Acid Synthase, Type I - metabolism | Obesity - metabolism | Insulin - metabolism | Animals | Duodenum - surgery | Triglycerides - blood | Blood Glucose - metabolism | Islands of Langerhans | Physiological aspects | Morphometrics (Biology) | Research | Lipid metabolism
Hepatic fatty acid metabolism | Duodenal-jejunal bypass | Hypothalamic obesity | Ki67 | Insulin secretion | MEDICINE, RESEARCH & EXPERIMENTAL | NERVOUS-SYSTEM | FATTY LIVER-DISEASE | Y GASTRIC BYPASS | INSULIN-SECRETION | BETA-CELL FUNCTION | METABOLISM | GLUCOSE | BIOLOGY | DYNAMICS | BARIATRIC SURGERY | WEIGHT | Liver - pathology | Cell Proliferation | Hypothalamic Diseases - physiopathology | Rats, Wistar | Cholesterol - blood | Hypothalamic Diseases - surgery | Male | Lipogenesis - genetics | Time Factors | Islets of Langerhans - metabolism | Islets of Langerhans - cytology | Islets of Langerhans - physiopathology | Gastric Bypass - methods | Fatty Acids - blood | Insulin Secretion | Animals, Newborn | Obesity - surgery | Reproducibility of Results | Fatty Liver - metabolism | Jejunum - surgery | Fatty Liver - physiopathology | Liver - metabolism | Insulin Resistance | Pancreas - pathology | Hypothalamic Diseases - metabolism | Obesity - physiopathology | Pancreas - metabolism | Random Allocation | Fatty Acid Synthase, Type I - metabolism | Obesity - metabolism | Insulin - metabolism | Animals | Duodenum - surgery | Triglycerides - blood | Blood Glucose - metabolism | Islands of Langerhans | Physiological aspects | Morphometrics (Biology) | Research | Lipid metabolism
Journal Article
Neurogastroenterology & Motility, ISSN 1350-1925, 02/2008, Volume 20, Issue 2, pp. 99 - 112
5‐Hydroxytryptamine4 (5‐HT4) receptors are an interesting target for the management of patients in need of gastrointestinal (GI) promotility treatment. They...
cisapride | constipation | prucalopride | 5‐HT4 receptor | tegaserod | Cisapride | receptor | Prucalopride | 5-HT | Constipation | Tegaserod | HUMAN JEJUNAL MUCOSA | HUMAN ATRIAL-FIBRILLATION | ENTERIC NERVOUS-SYSTEM | PHARMACOLOGICAL CHARACTERIZATION | SEROTONIN RECEPTORS | FUNCTIONAL GI DISORDERS | NEUROSCIENCES | CLINICAL NEUROLOGY | GUINEA-PIG INTESTINE | IN-VITRO | 5-HT4 receptor | CIRCULAR SMOOTH-MUSCLE | GASTROENTEROLOGY & HEPATOLOGY | IRRITABLE-BOWEL-SYNDROME | Gastrointestinal Agents - pharmacology | Animals | Gastrointestinal Diseases - physiopathology | Gastrointestinal Diseases - drug therapy | Humans | Gastrointestinal Motility - drug effects | Gastrointestinal Motility - physiology | Clinical Trials as Topic | Serotonin 5-HT4 Receptor Agonists | Serotonin Receptor Agonists - pharmacology
cisapride | constipation | prucalopride | 5‐HT4 receptor | tegaserod | Cisapride | receptor | Prucalopride | 5-HT | Constipation | Tegaserod | HUMAN JEJUNAL MUCOSA | HUMAN ATRIAL-FIBRILLATION | ENTERIC NERVOUS-SYSTEM | PHARMACOLOGICAL CHARACTERIZATION | SEROTONIN RECEPTORS | FUNCTIONAL GI DISORDERS | NEUROSCIENCES | CLINICAL NEUROLOGY | GUINEA-PIG INTESTINE | IN-VITRO | 5-HT4 receptor | CIRCULAR SMOOTH-MUSCLE | GASTROENTEROLOGY & HEPATOLOGY | IRRITABLE-BOWEL-SYNDROME | Gastrointestinal Agents - pharmacology | Animals | Gastrointestinal Diseases - physiopathology | Gastrointestinal Diseases - drug therapy | Humans | Gastrointestinal Motility - drug effects | Gastrointestinal Motility - physiology | Clinical Trials as Topic | Serotonin 5-HT4 Receptor Agonists | Serotonin Receptor Agonists - pharmacology
Journal Article
BMC Complementary and Alternative Medicine, ISSN 1472-6882, 06/2017, Volume 17, Issue 1, pp. 329 - 10
Background: Gastrointestinal motility disorder has been demonstrated to be regulated by acupuncture treatment. The mechanisms underlying the effects of...
Sympathetic pathway | LI11 | Parasympathetic pathway | Electroacupuncture (EA) | Jejunal motility | NEURAL MECHANISM | HETEROTOPIC ACUPOINTS | PROBIOTICS | ACUPUNCTURE STIMULATION | FUNCTIONAL GASTROINTESTINAL DISORDERS | REFLEX INHIBITION | THERAPY | INTEGRATIVE & COMPLEMENTARY MEDICINE | DOPAMINE | RECEPTORS | MODULATION | Electroacupuncture | Gastrointestinal Diseases - physiopathology | Humans | Rats | Gastrointestinal Diseases - therapy | Male | Acupuncture Therapy | Rats, Sprague-Dawley | Mice, Knockout | Gastrointestinal Motility | Animals | Jejunum - physiopathology | Acupuncture Points | Parasympathetic Nervous System - physiopathology | Usage | Care and treatment | Motility | Gastrointestinal diseases | Gastrointestinal system | Physiological aspects | Acupuncture | Research | vagotomy | Contractility | Exploration | Stimulation | Nervous system | Clenbuterol | Abdomen | Fibers | Studies | Rodents | Penicillin | Irritable bowel syndrome | Atropine | Sensory neurons | Mice | Acetylcholine | Propranolol | Laboratory animals | Drug dosages | Gastric motility | Parasympathetic nervous system
Sympathetic pathway | LI11 | Parasympathetic pathway | Electroacupuncture (EA) | Jejunal motility | NEURAL MECHANISM | HETEROTOPIC ACUPOINTS | PROBIOTICS | ACUPUNCTURE STIMULATION | FUNCTIONAL GASTROINTESTINAL DISORDERS | REFLEX INHIBITION | THERAPY | INTEGRATIVE & COMPLEMENTARY MEDICINE | DOPAMINE | RECEPTORS | MODULATION | Electroacupuncture | Gastrointestinal Diseases - physiopathology | Humans | Rats | Gastrointestinal Diseases - therapy | Male | Acupuncture Therapy | Rats, Sprague-Dawley | Mice, Knockout | Gastrointestinal Motility | Animals | Jejunum - physiopathology | Acupuncture Points | Parasympathetic Nervous System - physiopathology | Usage | Care and treatment | Motility | Gastrointestinal diseases | Gastrointestinal system | Physiological aspects | Acupuncture | Research | vagotomy | Contractility | Exploration | Stimulation | Nervous system | Clenbuterol | Abdomen | Fibers | Studies | Rodents | Penicillin | Irritable bowel syndrome | Atropine | Sensory neurons | Mice | Acetylcholine | Propranolol | Laboratory animals | Drug dosages | Gastric motility | Parasympathetic nervous system
Journal Article
Gut, ISSN 0017-5749, 12/2014, Volume 63, Issue 12, pp. 1979 - 1979
SMALL INTESTINE | ENTEROSCOPY | LYMPHOMA | CELIAC DISEASE | INTESTINAL OBSTRUCTION | GASTROENTEROLOGY & HEPATOLOGY | Intestinal Obstruction - physiopathology | Intestinal Obstruction - etiology | Glucocorticoids - administration & dosage | Jejunum - pathology | Humans | Jejunal Diseases - diagnosis | Tomography, X-Ray Computed - methods | Abdominal Pain | Endoscopy, Digestive System - methods | Jejunal Diseases - etiology | Administration, Intravenous | Vomiting | Weight Loss | Enteropathy-Associated T-Cell Lymphoma - diagnosis | Jejunal Diseases - physiopathology | Therapeutics | Female | Aged | Enteropathy-Associated T-Cell Lymphoma - complications | Enteropathy-Associated T-Cell Lymphoma - physiopathology | Enteropathy-Associated T-Cell Lymphoma - drug therapy | Intestinal Obstruction - diagnosis
Journal Article
Clinical Neuropharmacology, ISSN 0362-5664, 05/2008, Volume 31, Issue 3, pp. 151 - 166
Objectives: We report here on the experience with continuous jejunal levodopa infusion in 13 German parkinsonian patients who have motor and nonmotor...
Jejunal infusion | Parkinson disease | Levodopa | Continuous dopaminergic stimulation | Motor complications | DUODENAL INFUSION | SUBTHALAMIC NUCLEUS STIMULATION | ON-OFF FLUCTUATIONS | jejunal infusion | motor complications | CLINICAL NEUROLOGY | TRIAL | PHARMACOKINETICS | levodopa | continuous dopaminergic stimulation | L-DOPA | DOUBLE-BLIND | APOMORPHINE | TERM-FOLLOW-UP | PHARMACOLOGY & PHARMACY | DYSKINESIAS | Dyskinesias - drug therapy | Parkinson Disease - complications | Catheterization | Humans | Middle Aged | Dyskinesias - physiopathology | Male | Treatment Outcome | Parkinson Disease - drug therapy | Motor Activity | Parkinson Disease - physiopathology | Jejunum | Levodopa - administration & dosage | Intubation, Gastrointestinal | Adult | Antiparkinson Agents - administration & dosage | Dyskinesias - complications
Jejunal infusion | Parkinson disease | Levodopa | Continuous dopaminergic stimulation | Motor complications | DUODENAL INFUSION | SUBTHALAMIC NUCLEUS STIMULATION | ON-OFF FLUCTUATIONS | jejunal infusion | motor complications | CLINICAL NEUROLOGY | TRIAL | PHARMACOKINETICS | levodopa | continuous dopaminergic stimulation | L-DOPA | DOUBLE-BLIND | APOMORPHINE | TERM-FOLLOW-UP | PHARMACOLOGY & PHARMACY | DYSKINESIAS | Dyskinesias - drug therapy | Parkinson Disease - complications | Catheterization | Humans | Middle Aged | Dyskinesias - physiopathology | Male | Treatment Outcome | Parkinson Disease - drug therapy | Motor Activity | Parkinson Disease - physiopathology | Jejunum | Levodopa - administration & dosage | Intubation, Gastrointestinal | Adult | Antiparkinson Agents - administration & dosage | Dyskinesias - complications
Journal Article